SCHEMBL7902633

SCHEMBL7902633

O=Cc1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
CYP2A6 P11509 1/20 0.55
TRIM24 O15164 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
TP53 P04637 1/20 0.43
IP6K1 Q92551 1/20 0.42
EGFR P00533 1/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
AXL P30530 1/20 0.41
KMO O15229 1/20 0.40
RAB9A P51151 1/20 0.39
UNG P13051 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664238 0.95 ALDH1A1 (0.55) ALDH1A1CYP2A6TRIM24TRIM33CA12
Benzaldehyde SCHEMBL1389484 0.90 ALDH1A1 (0.70) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL5446914 0.90 ALDH1A1 (0.60) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL16381738 0.88 ALDH1A1 (0.59) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL28460866 0.86 TRIM24 (0.67) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL31503979 0.85 TRIM24 (0.50) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL16050814 0.85 MAOA (0.48) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL18001570 0.85 ALDH1A1 (0.44) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL16406661 0.85 ALDH1A1 (0.44) ALDH1A1CYP2A6TRIM24TRIM33CA12
SCHEMBL14426269 0.85 ALDH1A1 (0.50) ALDH1A1CYP2A6TRIM24TRIM33CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416172-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-12-29 US disclosed
US-10544360-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2020-01-28 US disclosed
CN-105377863-B polycyclic compounds 默克专利有限公司 2019-03-01 CN disclosed
US-10205106-B2 Polycyclic compounds MERCK PATENT GMBH (DE) 2019-02-12 US disclosed
US-10205106-B2 Polycyclic compounds MERCK PATENT GMBH (DE) 2019-02-12 US disclosed
EP-2787053-B1 Polymeric materials MERCK PATENT GMBH (DE) 2018-11-21 EP disclosed
EP-3016959-B1 POLYCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-12-27 EP disclosed
EP-3016959-B1 POLYCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-12-27 EP disclosed
EP-2627732-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2017-12-20 EP disclosed
US-20160204358-A1 POLYCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2016-07-14 US disclosed
US-20130207095-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Fraunhofer-Gesellschaft Forderung E.V. (DE) 2013-08-15 US disclosed
US-20130207095-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Fraunhofer-Gesellschaft Forderung E.V. (DE) 2013-08-15 US disclosed
US-20130207095-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Fraunhofer-Gesellschaft Forderung E.V. (DE) 2013-08-15 US disclosed
WO-2012048900-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. . (DE) 2012-04-19 WO disclosed
CN-1099407-C Novel amino acid derivatives with improved multi-drug resistance activity VERTEX PAHRMACEUTICAL INC (US) 2003-01-22 CN disclosed
US-6274556-B1 ADMINISTERING POLYPEPTIDE DERIVATIVE TO TREAT INFLAMMATORY BOWEL DISEASE AND TO PREVENT LEUKOCYTE INFILTRATION INTO TISSUES MILLENNIUM PHARMACEUTICALS, INC. 2001-08-14 US disclosed
US-5942532-A INHIBITORS OF HISTIDINE PROTEIN KINASE; BACTERIA RESISTANT TO OTHER ANTIBIOTICS ORTHO PHARMACEUTICAL CORPORATION (US) 1999-08-24 US disclosed
WO-1999011627-A1 2-SUBSTITUTED PHENYL-BENZIMIDAZOLE ANTIBACTERIAL AGENTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-03-11 WO disclosed
EP-0871670-A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR Leukosite, Inc. (US) 1998-10-21 EP disclosed
WO-1997025351-A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR LEUKOSITE, INC. (US) 1997-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416172-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NDUFS5, KCNJ2, EHMT2 ALDH1A1 524/4885CYP2A6 3913/4885TRIM24 3545/4885
US-20160204358-A1 POLYCYCLIC COMPOUNDS VDAC2, VDAC3, KCNC1 ALDH1A1 2257/4885CYP2A6 3735/4885TRIM24 3126/4885
US-10205106-B2 Polycyclic compounds VDAC2, VDAC3, KCNC1 ALDH1A1 2257/4885CYP2A6 3735/4885TRIM24 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.